Global Oral Cholera Vaccine Market Growth 2023-2029

Global Oral Cholera Vaccine Market Growth 2023-2029

The global Oral Cholera Vaccine market size is projected to grow from US$ 83 million in 2022 to US$ 140.1 million in 2029; it is expected to grow at a CAGR of 7.7% from 2023 to 2029.

Global top four manufacturers of oral cholera vaccine include EuBiologics, Sanofi, United Biotech and Vabiotech, etc. The leading player is EuBiologics, who makes up over 40%.

South Korea is the largest producer, with a market share more than 80%, followed by India (10%). Mid East & Africa gains the segment, with a share about 30%.

Euvichol-Plus is the key segment among three types of oral cholera vaccine, accounting for over 40%. In terms of application, main uses of oral cholera vaccine are preventive campaigns and outbreak response.

LPI (LP Information)' newest research report, the “Oral Cholera Vaccine Industry Forecast” looks at past sales and reviews total world Oral Cholera Vaccine sales in 2022, providing a comprehensive analysis by region and market sector of projected Oral Cholera Vaccine sales for 2023 through 2029. With Oral Cholera Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Oral Cholera Vaccine industry.

This Insight Report provides a comprehensive analysis of the global Oral Cholera Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Oral Cholera Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Oral Cholera Vaccine market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Oral Cholera Vaccine and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Oral Cholera Vaccine.

This report presents a comprehensive overview, market shares, and growth opportunities of Oral Cholera Vaccine market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type
Euvichol-Plus
DUKORAL
Shanchol
Others

Segmentation by application
Preventive Campaigns
Outbreak Response

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
PaxVax
Sanofi
Valneva
EuBiologics
United Biotech
Vabiotech
PaxVax

Key Questions Addressed in this Report

What is the 10-year outlook for the global Oral Cholera Vaccine market?

What factors are driving Oral Cholera Vaccine market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Oral Cholera Vaccine market opportunities vary by end market size?

How does Oral Cholera Vaccine break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.